Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03218631 · ClinicalTrials.gov registry record · Phase 1
Oxandrolone in Healthy Adults: A Relative Bioavailability Study
A Phase 1 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT03218631 is a Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 6 participants.
The verdict
NCT03218631, a Phase 1 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
To assess the pharmacokinetics and relative bioavailability of a single dose of approximately 0.1 mg/kg of a medium chain triglyceride (MCT) oil oxandrolone solution vs. tablets in a small cohort of healthy adults.
Interventions
- DRUG Oxandrin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-07-10 |
| Est. Completion | 2017-11-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03218631
The ClinicalTrials.gov registry entry for NCT03218631 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oxandrin is the first listed.
NCT03218631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03218631 about?
NCT03218631 is a clinical study titled "Oxandrolone in Healthy Adults: A Relative Bioavailability Study". To assess the pharmacokinetics and relative bioavailability of a single dose of approximately 0.1 mg/kg of a medium chain triglyceride (MCT) oil oxandrolone solution vs. tablets in a small cohort of healthy adults.
What is the current status of trial NCT03218631?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2017-07-10. Estimated completion is 2017-11-30.
What interventions are being tested in trial NCT03218631?
The interventions under investigation include: Oxandrin (DRUG).
Who is sponsoring clinical trial NCT03218631?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.